Statistics by Country for Pancreatic cancer
|
About these extrapolations of prevalence and incidence statistics for Pancreatic cancer:
These statistics are calculated extrapolations of various prevalence or incidence rates
against the populations of a particular country or region.
The statistics used for prevalence/incidence of Pancreatic cancer are typically based on US, UK, Canadian or Australian statistics.
This extrapolation calculation is automated and does not take into account any genetic, cultural, environmental, social, racial or other differences
across the various countries and regions for which the extrapolated Pancreatic cancer statistics below refer to.
As such, these extrapolations may be highly inaccurate (especially for developing or third-world countries) and only give a general indication (or even a meaningless indication)
as to the actual prevalence or incidence of Pancreatic cancer in that region.
About prevalence and incidence statistics in general for Pancreatic cancer: The word 'prevalence' of Pancreatic cancer usually means the estimated population of people who are managing Pancreatic cancer at any given time (i.e. people with Pancreatic cancer). The term 'incidence' of Pancreatic cancer means the annual diagnosis rate, or the number of new cases of Pancreatic cancer diagnosed each year (i.e. getting Pancreatic cancer). Hence, these two statistics types can differ: a short disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics. |
Incidence (annual) of Pancreatic cancer: 30,300 annual cases (SEER 2002 estimate)
Incidence Rate for Pancreatic cancer: approx 1 in 8,976 or 0.01% or 30,300 people in USA [about data]
Extrapolation of Incidence Rate for Pancreatic cancer to Countries and Regions: The following table attempts to extrapolate the above incidence rate for Pancreatic cancer to the populations of various countries and regions. As discussed above, these incidence extrapolations for Pancreatic cancer are only estimates and may have limited relevance to the actual incidence of Pancreatic cancer in any region:
| Country/Region | Extrapolated Incidence | Population Estimated Used |
| Pancreatic cancer in North America (Extrapolated Statistics) | ||
| USA | 32,712 | 293,655,4051 |
| Canada | 3,621 | 32,507,8742 |
| Pancreatic cancer in Europe (Extrapolated Statistics) | ||
| Austria | 910 | 8,174,7622 |
| Belgium | 1,152 | 10,348,2762 |
| Britain (United Kingdom) | 6,713 | 60,270,708 for UK2 |
| Czech Republic | 138 | 1,0246,1782 |
| Denmark | 603 | 5,413,3922 |
| Finland | 580 | 5,214,5122 |
| France | 6,731 | 60,424,2132 |
| Greece | 1,186 | 10,647,5292 |
| Germany | 9,181 | 82,424,6092 |
| Iceland | 32 | 293,9662 |
| Hungary | 1,117 | 10,032,3752 |
| Liechtenstein | 3 | 33,4362 |
| Ireland | 442 | 3,969,5582 |
| Italy | 6,467 | 58,057,4772 |
| Luxembourg | 51 | 462,6902 |
| Monaco | 3 | 32,2702 |
| Netherlands (Holland) | 1,817 | 16,318,1992 |
| Poland | 4,302 | 38,626,3492 |
| Portugal | 1,172 | 10,524,1452 |
| Spain | 4,487 | 40,280,7802 |
| Sweden | 1,001 | 8,986,4002 |
| Switzerland | 830 | 7,450,8672 |
| United Kingdom | 6,713 | 60,270,7082 |
| Wales | 325 | 2,918,0002 |
| Pancreatic cancer in the Balkans (Extrapolated Statistics) | ||
| Albania | 394 | 3,544,8082 |
| Bosnia and Herzegovina | 45 | 407,6082 |
| Croatia | 500 | 4,496,8692 |
| Macedonia | 227 | 2,040,0852 |
| Serbia and Montenegro | 1,205 | 10,825,9002 |
| Pancreatic cancer in Asia (Extrapolated Statistics) | ||
| Bangladesh | 15,744 | 141,340,4762 |
| Bhutan | 243 | 2,185,5692 |
| China | 144,687 | 1,298,847,6242 |
| East Timor | 113 | 1,019,2522 |
| Hong Kong s.a.r. | 763 | 6,855,1252 |
| India | 118,645 | 1,065,070,6072 |
| Indonesia | 26,562 | 238,452,9522 |
| Japan | 14,184 | 127,333,0022 |
| Laos | 675 | 6,068,1172 |
| Macau s.a.r. | 49 | 445,2862 |
| Malaysia | 2,620 | 23,522,4822 |
| Mongolia | 306 | 2,751,3142 |
| Philippines | 9,607 | 86,241,6972 |
| Papua New Guinea | 603 | 5,420,2802 |
| Vietnam | 9,208 | 82,662,8002 |
| Singapore | 485 | 4,353,8932 |
| Pakistan | 17,734 | 159,196,3362 |
| North Korea | 2,528 | 22,697,5532 |
| South Korea | 5,373 | 48,233,7602 |
| Sri Lanka | 2,217 | 19,905,1652 |
| Taiwan | 2,534 | 22,749,8382 |
| Thailand | 7,225 | 64,865,5232 |
| Pancreatic cancer in Eastern Europe (Extrapolated Statistics) | ||
| Azerbaijan | 876 | 7,868,3852 |
| Belarus | 1,148 | 10,310,5202 |
| Bulgaria | 837 | 7,517,9732 |
| Estonia | 149 | 1,341,6642 |
| Georgia | 522 | 4,693,8922 |
| Kazakhstan | 1,686 | 15,143,7042 |
| Latvia | 256 | 2,306,3062 |
| Lithuania | 401 | 3,607,8992 |
| Romania | 2,490 | 22,355,5512 |
| Russia | 16,038 | 143,974,0592 |
| Slovakia | 604 | 5,423,5672 |
| Slovenia | 224 | 2,011,473 2 |
| Tajikistan | 781 | 7,011,556 2 |
| Ukraine | 5,317 | 47,732,0792 |
| Uzbekistan | 2,942 | 26,410,4162 |
| Pancreatic cancer in Australasia and Southern Pacific (Extrapolated Statistics) | ||
| Australia | 2,218 | 19,913,1442 |
| New Zealand | 444 | 3,993,8172 |
| Pancreatic cancer in the Middle East (Extrapolated Statistics) | ||
| Afghanistan | 3,176 | 28,513,6772 |
| Egypt | 8,479 | 76,117,4212 |
| Gaza strip | 147 | 1,324,9912 |
| Iran | 7,519 | 67,503,2052 |
| Iraq | 2,826 | 25,374,6912 |
| Israel | 690 | 6,199,0082 |
| Jordan | 625 | 5,611,2022 |
| Kuwait | 251 | 2,257,5492 |
| Lebanon | 420 | 3,777,2182 |
| Libya | 627 | 5,631,5852 |
| Saudi Arabia | 2,873 | 25,795,9382 |
| Syria | 2,007 | 18,016,8742 |
| Turkey | 7,674 | 68,893,9182 |
| United Arab Emirates | 281 | 2,523,9152 |
| West Bank | 257 | 2,311,2042 |
| Yemen | 2,230 | 20,024,8672 |
| Pancreatic cancer in South America (Extrapolated Statistics) | ||
| Belize | 30 | 272,9452 |
| Brazil | 20,508 | 184,101,1092 |
| Chile | 1,762 | 15,823,9572 |
| Colombia | 4,713 | 42,310,7752 |
| Guatemala | 1,590 | 14,280,5962 |
| Mexico | 11,692 | 104,959,5942 |
| Nicaragua | 597 | 5,359,7592 |
| Paraguay | 689 | 6,191,3682 |
| Peru | 3,068 | 27,544,3052 |
| Puerto Rico | 434 | 3,897,9602 |
| Venezuela | 2,786 | 25,017,3872 |
| Pancreatic cancer in Africa (Extrapolated Statistics) | ||
| Angola | 1,222 | 10,978,5522 |
| Botswana | 182 | 1,639,2312 |
| Central African Republic | 416 | 3,742,4822 |
| Chad | 1,062 | 9,538,5442 |
| Congo Brazzaville | 333 | 2,998,0402 |
| Congo kinshasa | 6,496 | 58,317,0302 |
| Ethiopia | 7,946 | 71,336,5712 |
| Ghana | 2,312 | 20,757,0322 |
| Kenya | 3,674 | 32,982,1092 |
| Liberia | 377 | 3,390,6352 |
| Niger | 1,265 | 11,360,5382 |
| Nigeria | 1,977 | 12,5750,3562 |
| Rwanda | 917 | 8,238,6732 |
| Senegal | 1,208 | 10,852,1472 |
| Sierra leone | 655 | 5,883,8892 |
| Somalia | 925 | 8,304,6012 |
| Sudan | 4,360 | 39,148,1622 |
| South Africa | 4,951 | 44,448,4702 |
| Swaziland | 130 | 1,169,2412 |
| Tanzania | 4,018 | 36,070,7992 |
| Uganda | 2,939 | 26,390,2582 |
| Zambia | 1,228 | 11,025,6902 |
| Zimbabwe | 409 | 1,2671,8602 |
Lifetime risk for Pancreatic cancer: 1 in 195 women and 1 in 36 men will develop pancreatic cancer during their lifetime in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
Footnotes:
1. US Census Bureau, Population Estimates, 2004
2. US Census Bureau, International Data Base, 2004
Last revision: June 5, 2003
Medical Tools & Articles:
Next articles:
Medical Articles: